Diverse microbial exposure - Consequences for vaccine development

Vaccine

Volumn 30, Issue 29, 2012, Pages 4336-4340

  Björkstén, Bengt ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

Author keywords

Adjuvant; Immune regulation; Microbiota; Probiotics; Vaccines

Indexed keywords

CHICKENPOX VACCINE; CHOLERA VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MUMPS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; PROBIOTIC AGENT; RUBELLA VACCINE; TETANUS TOXOID;

ALLERGIC DISEASE; ANTIBODY RESPONSE; BIFIDOBACTERIUM LONGUM; COMMENSAL; GERMFREE ANIMAL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFANCY; INFLUENZA VACCINATION; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; LISTERIA MONOCYTOGENES; MICROBIAL COLONIZATION; NONHUMAN; PERSONAL HYGIENE; POSTNATAL CARE; POSTNATAL DEVELOPMENT; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRULENCE;

ANIMALS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; HYGIENE HYPOTHESIS; HYPERSENSITIVITY; INFANT; METAGENOME; PREGNANCY; PROBIOTICS; VACCINATION;

EID: 84861962385     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.074     Document Type: Review

References (45)

1. Asher M.I., Montefort S., Björkstén B., Lai C.K., Strachan D.P., Weiland S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
2. Gerrard J., Geddes C., Reggin P., Gerrard C., Horne S. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976, 37:91-100.
3. Strachan D. Hay fever, hygiene and household size. Br Med J 1989, 299:1259-1266.
4. von Mutius E. Allergies, infections and the hygiene hypothesis - the epidemiological evidence. Immunobiology 2007, 212:433-439.
5. Benn C.S., Melbye M., Wohlfahrt J., Björkstén B., Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. Br Med J 2004, 328:1223-1230.
6. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
7. Stene L.C., Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001, 357:607-608.
8. Bråbäck L., Breborowicz A., Julge K., Knutsson A., Riikjärv M., Vasar M., et al. Risk factors for respiratory symptoms and atopic sensitization in the Baltic area. Arch Dis Child 1995, 72:487-493.
9. von Mutius E., Fritzsch C., Weiland S.K., Roll G., Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. Br Med J 1992, 305:1395-1399.
10. Björkstén B., Dumitrascu D., Foucard T., Khetsuriani N., Khaitov R., Leja M., et al. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur Respir J 1998, 12:432-437.
11. Holt P.G., van den Biggelaar A.H. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the role of infections in allergy: atopic asthma as a paradigm. Clin Exp Immunol 2010, 160:22-26.
12. Rook G.A. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009, 126:3-11.
13. Rook G.A. Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis 2011, 29:144-153.
14. Lewis D.B., Gern J.E., Hill H.R., Friedlander S.L., La Pine T.R., Lemanske R.F., et al. Newborn immunology: relevance to the clinician. Curr Probl Pediatr Adolesc Health Care 2006, 36:189-204.
15. Fagerås M, Tomicic S, Voor T, Björkstén B, Jenmalm MC. Slow salivary secretory IgA maturation may relate to low microbial pressure and allergic symptoms in sensitized children. Pediatr Res, in press 2011: Aug 18; Epub ahead of print, PMID 21857384.
16. Böttcher M.F., Jenmalm M.C., Voor T., Julge K., Holt P.G., Björkstén B. Cytokine responses to allergens during the first 2 years of life in Estonian and Swedish children. Clin Exp Allergy 2006, 36:619-628.
17. Lauener R.P., Birchler T., Adamski J., Braun-Fahrlander C., Bufe A., Herz U., et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002, 360:465-466.
18. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
19. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997, 159:1739-1745.
20. Björkstén B. The hygiene hypothesis: do we still believe in it?. Nestle Nutr Workshop Ser 2009, 64:11-18. discussion 8-22, 251-7.
21. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
22. Gaskins H.R., Croix J.A., Nakamura N., Nava G.M. Impact of the intestinal microbiota on the development of mucosal defense. Clin Infect Dis 2008, 46(February (Suppl. 2)):S80-S86. discussion S144-51.
23. Hooper L., Gordon J. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
24. Demengeot J., Zelenay S., Moraes-Fontes M.F., Caramalho I., Coutinho A. Regulatory T cells in microbial infection. Springer Semin Immunopathol 2006, 28:41-50.
25. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
26. Abrahamsson T, Abelius M, Forsberg A, Björkstén B, Jenmalm M. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy, in press.
27. Sjögren Y.M., Tomicic S., Lundberg A., Böttcher M.F., Björkstén B., Sverremark-Ekström E., et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009, 39:1842-1851.
28. Björkstén B. Environmental influences on the development of the immune system: consequences for disease outcome. Nestle Nutr Workshop Ser 2008, 61:243-254.
29. El-Zein M., Parent M.E., Benedetti A., Rousseau M.C. Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol 2010, 39:469-486.
30. Annus T., Montgomery S.M., Riikjärv M.A., Björkstén B. Atopic disorders among Estonian school children in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 2004, 59:1068-1073.
31. Youngster I., Kozer E., Lazarovitch Z., Broide E., Goldman M. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch Dis Child 2011, 96:345-349.
32. Koppen S., de Groot R., Neijens H.J., Nagelkerke N., van Eden W., Rumke H.C. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 2004, 22:3375-3385.
33. Sanchez-Solis M., Garcia-Marcos L. Do vaccines modify the prevalence of asthma and allergies?. Expert Rev Vaccines 2006, 5:631-640.
34. Ponvert C. Vaccines and allergy. Rev Fr Allergol Immunol (Paris) 2007, 47:9-15.
35. Kukkonen K., Nieminen T., Poussa T., Savilahti E., Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy - a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol 2006, 17:416-421.
36. Matsuda F., Chowdhury M.I., Saha A., Asahara T., Nomoto K., Tarique A.A., et al. Evaluation of a probiotics, bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 2011, 29:1855-1858.
37. Perez N., Iannicelli J.C., Girard-Bosch C., Gonzalez S., Varea A., Disalvo L., et al. Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur J Nutr 2010, 49:173-179.
38. Soh S.E., Ong D.Q., Gerez I., Zhang X., Chollate P., Shek L.P., et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010, 28:2577-2579.
39. West C.E., Gothefors L., Granstrom M., Kayhty H., Hammarstrom M.L., Hernell O. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2008, 19:53-60.
40. Davidson L.E., Fiorino A.M., Snydman D.R., Hibberd P.L. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 2011, 65:501-507.
41. de Vrese M., Rautenberg P., Laue C., Koopmans M., Herremans T., Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 2005, 44:406-413.
42. Boge T., Remigy M., Vaudaine S., Tanguy J., Bourdet-Sicard R., van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009, 27:5677-5684.
43. Guimaraes V.D., Gabriel J.E., Lefevre F., Cabanes D., Gruss A., Cossart P., et al. Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect 2005, 7:836-844.
44. Medina M., Vintini E., Villena J., Raya R., Alvarez S. Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections. Bioeng Bugs 2010, 1:313-325.
45. Van Huynegem K., Loos M., Steidler L. Immunomodulation by genetically engineered lactic acid bacteria. Front Biosci 2009, 14:4825-4835.